Merck KGaA (MRK.F)
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
142.30-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+31.8%
The outlook
Merck KGaA currently reads as leaning bullish based on buy — 2.2 avg of 14 analysts, above its 50- & 200-day averages, 88% of the way from its 52-week low to high, avg target +3% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 14 analysts
Price trendAbove its 50- & 200-day averages
52-week range88% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 14 analysts146.29average target+2.8% vs now
Now 142.30
Low 121.00High 179.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$61.87B
52-wk high
147.95
52-wk low
100.65
50-day avg
136.73
200-day avg
122.15
Trailing P/E
24.4